Business
In this episode, Greg and Rob catch up on developments surrounding the J&J 340B rebate proposal, including HRSA’s response. They’ll address some outstanding questions from the recent SpendMend webinar on the topic.
In the intro, they recap some updates regarding contract pharmacy litigation and thoughts on how DSCSA and product serialization data might impact 340B operations.
If you missed it before, you can watch our webinar on the J&J 340B rebate model here: https://ww2.spendmend.com/webinar-jj-340b-rebate-model-what-covered-entities-need-to-know/
More Episodes
Ep 84 | CMS OPPS Drug Acquisition Cost Survey (ODACS)
2026-01-26
769
2026-01-26
769
Ep 83 | 340B Rebates Are on Hold
2026-01-12
715
2026-01-12
715
Ep 82 | Recap of 340B Developments from 2025
2025-12-22
730
2025-12-22
730
Ep 81 | 340B Rebate Q&A with Beacon
2025-12-08
989
2025-12-08
989
Ep 79 | 340B Rebate Model Update
2025-11-03
1.2k
2025-11-03
1.2k
Ep 77 | DSH Hospital Threats
2025-09-29
711
2025-09-29
711
Ep 76 | HRSA DRL Updates & 340B Rebate Comments
2025-09-15
801
2025-09-15
801
Ep 75 | 340B Rebate Guidance Update – HRSA FAQs
2025-09-01
887
2025-09-01
887
Ep 73 | Coalition Recap & 340B Rebate Guidance Release
2025-08-11
742
2025-08-11
742
Ep 72 | Insulin & EpiPen 340B Policy Changes for FQHCs
2025-07-21
573
2025-07-21
573
Ep 70 | 340B Updates – IRA Guidance and Rebate Models
2025-06-16
672
2025-06-16
672
Ep 69 | Quick 340B Update
2025-06-02
681
2025-06-02
681
Ep 68 | 340B Hot Topics Discussion
2025-05-12
783
2025-05-12
783
Ep 67 | 340B Location Issues – Webinar Follow Up
2025-04-21
701
2025-04-21
701
Ep 66 | OPAIS Database Compliance Tips
2025-04-07
811
2025-04-07
811
Get this podcast on your
phone, FREE
